Community-based strategy to improve cervical cancer screening access

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates a community health worker (CHW) delivered self-sample HPV testing approach to enhance cervical cancer screening among women in low-resource communities in Texas. It aims to determine the feasibility and acceptability of this method, focusing on screening uptake and the experiences of participants. The study also explores follow-up attendance for those who test positive for high-risk HPV and assesses how well the intervention fits within the community context.

Why it matters

Who can join: the full rules

Inclusion Criteria:

To be eligible to participate in this study, an individual must meet all of the following criteria:

* Provision of signed and dated informed consent form
* Currently resident in RGV or other low-resource community in Texas
* Stated willingness to comply with all study procedures
* Females; Age ≥25 years
* Have no history of hysterectomy with removal of the cervix
* Have no history of cervical cancer or high-grade dysplasia
* Have not had a Pap test in the past 3.5 years or Pap/HPV co-test in the past 5.5 years.

Exclusion Criteria:

An individual who meets any of the following criteria will be excluded from participation in this study:

* Unable to communicate in English or Spanish
* Lack valid telephone contact information
* Report being currently pregnant.

Where it's running

• University of Texas at Austin
  Austin, Texas, United States Recruiting
• M D Anderson Cancer Center
  Houston, Texas, United States Recruiting

Study contacts

• Principal investigator: Jane Montealegre, M D — M.D. Anderson Cancer Center
• Study coordinator: Jane Montealegre, M D
• Email: jrmontealegre@mdanderson.org
• Phone: (281) 814-7118

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Can people collect their own vaginal sample for HPV testing as well as clinician collection for comparison?

  This study tests whether individuals can correctly use a self-collection device to gather a vaginal sample for high-risk HPV screening and whether the self-collected sample agrees with clinician-collected samples.

  Recruiting at 11 sites Mel Mont Medical · Phoenix, Arizona and 10 other locations · NCT07758140

• Two-probe thermal ablation for cervical precancer in WLWH in South Africa

  This study tests whether using two probes for thermal ablation is safer or more effective than one probe for treating cervical precancer in women living with HIV in South Africa.

  Recruiting Fred Hutchinson Cancer Center · Durban · NCT07645378

• Two-probe thermal ablation for cervical precancer in WLWH in Zimbabwe

  This study tests whether using two TA probes (endocervical and ectocervical) is better than one probe for treating cervical precancer in women living with HIV in Zimbabwe.

  Recruiting Fred Hutchinson Cancer Center · Harare · NCT07645352

• Digital tools to boost HPV vaccination intentions among Nigerian caregivers

  This study tests whether different online content can help Nigerian parents of unvaccinated girls ages 9-14 decide to vaccinate their daughters against HPV.

  Recruiting University of Pennsylvania · Lagos · NCT07498075

• HPV monitoring after chemoradiotherapy for cervical cancer

  This project will test whether HPV detected on cervical swabs and in blood can find cancer recurrence in people with stage IB–IVA cervical cancer after curative chemoradiotherapy.

  Recruiting General University Hospital, Prague · Prague · NCT07493928

• Two-probe thermal ablation for cervical precancer in HIV+ women in Kenya

  This study tests whether using two probes for thermal ablation is more effective and acceptable than one probe for treating cervical precancer in women living with HIV in Kenya.

  Recruiting Fred Hutchinson Cancer Center · Nairobi · NCT07468695

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.